Across TCGA pan-cancer cohorts, DSCAM RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated DSCAM data layer compared with 11 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DSCAM RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DSCAM expression acts as an unfavorable survival marker, although some lineages such as SCLC and LGG show a favorable association.
HNSC, SCLC, and LGG are the cancer types where DSCAM RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.